Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting

PURPOSE: To evaluate the safety and efficacy of favipiravir, which is prescribed for the treatment of patients with mild-to-moderate coronavirus disease 2019 (COVID-19) in India. PATIENTS AND METHODS: This was a prospective, open-label, multicenter, single-arm postmarketing study conducted in India....

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Pavan Kumar, Patil, Saiprasad, Khobragade, Akash, Balki, Akash, Raj, Aneesh, Kalikar, Mrunalini, Reddy, Raghavendra, Shinde, Ravindra, CR, Jayanthi, Mutha, Abhinandan, Boyilla, Nagaraju, Rajadhyaksha, Girish C, Karnik, Niteen, Bhagat, Sagar, Pendse, Amol, Dhage, Priyanka, Wu, Wen, Rangwala, Shabbir, Barkate, Hanmant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078344/
https://www.ncbi.nlm.nih.gov/pubmed/35535140
http://dx.doi.org/10.2147/IJGM.S349241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078344/
https://www.ncbi.nlm.nih.gov/pubmed/35535140
http://dx.doi.org/10.2147/IJGM.S349241

Ejemplares similares